How New York is preparing for bird flu

Delivered every Monday by 10 a.m., New York Health Care is your guide to the week’s top health care news and policy in Albany and around the Empire State.
Jul 01, 2024 View in browser
 
Weekly New York Health Care newsletter logo.

By Maya Kaufman

Good morning and welcome to the Weekly New York Health Care newsletter, where we keep you posted on what's coming up this week in health care news, and offer a look back at the important news from last week.

Beat Memo

Bird flu preparations are on local public health officials’ radar, as the H5N1 virus continues to spread rapidly among dairy cows across the U.S.

There have been no human or livestock cases of bird flu in New York to date, state Health Department spokesperson Erin Clary told POLITICO on Thursday.

And the department is on alert: It expanded wastewater surveillance and, as requested by the CDC, extended its influenza surveillance beyond the typical end of the regular respiratory illness season in May.

Should the need arise, the state-run Wadsworth Center Public Health Laboratory has sufficient capacity to test several hundred human H5N1 specimens daily. Supplemental funding and supplies are available from a national repository in the event of an emergency, so the state could expand its diagnostic capacity to tens of thousands of tests per day.

In New York City, the Department of Health and Mental Hygiene is putting contracts into place for a pharmacy to provide same-day medication delivery, a public health call center, a vaccination and specimen collection service and temporary staffing agencies that could be quickly leveraged during an emergency.

The city is also placing a “hold order” with a national medical supply distributor for personal protective equipment, meaning it can be called in at any time and distributed to local health care facilities — in contrast to static stockpiles, which require maintenance and replenishment as products expire.

“From Covid-19 to isolated disease outbreaks, the Health Department has a long and distinguished record of emergency response,” New York City Health Commissioner Ashwin Vasan said.

Hospitals play a key role in identifying patients with suspected emerging pathogens, but they have to contend with the lack of a readily available PCR test to detect the H5N1 subtype.

At NYC Health + Hospitals, researchers monitoring wastewater for influenza are developing genetic tests for H5N1 to enhance early detection efforts.

The Greater New York Hospital Association says hospitals are prepared for any bird flu cases with 60-day stockpiles of personal protective equipment and flex-and-surge plans that can be activated for any influx of patients.

“Our hospitals continuously work to ensure readiness for these infections by implementing protocols for screening, ensuring precautions are in place to minimize transmission, and informing public health authorities and other key stakeholders,” Erin DuPree, the association’s senior vice president and physician executive for quality and clinical initiatives, said in a statement.

IN OTHER NEWS:

City and state health officials are investigating reports of hepatitis C infection in multiple patients who underwent procedures between Sept. 1, 2022, and Aug. 31, 2023, at American Access Care locations in the Bronx, Plainview and Queens, the state Health Department said in a release Friday.

The department is still investigating but does not consider the situation a broader public health risk, given that exposure has been limited to a very specific group of patients.

All patients who had procedures at affected clinics during that time frame are being notified by American Access Care and being offered no-cost, confidential blood testing.

Gov. Kathy Hochul signed a legislative package Friday to support New Yorkers living with HIV/AIDS. The package includes measures to update the state’s HIV testing laws to align with CDC guidance and to prohibit insurers from requesting prior authorization for covered antiretroviral drugs for treatment or prevention of HIV or AIDS.

ON THE AGENDA:

Monday at 11 a.m. The NYC Health + Hospitals board of directors hosts a finance committee meeting.

Monday at 12 p.m. The NYC Health + Hospitals board of directors hosts a capital committee meeting.

MAKING ROUNDS:

Syra Madad was named chief biopreparedness officer of NYC Health + Hospitals, leading the system-wide special pathogens team and overseeing emergency preparedness drills.

GOT TIPS? Send story ideas and feedback to Maya Kaufman at mkaufman@politico.com.

Want to receive this newsletter every weekday? Subscribe to POLITICO Pro. You’ll also receive daily policy news and other intelligence you need to act on the day’s biggest stories.

What you may have missed

VNS Health will pay nearly $1 million to settle allegations that it fraudulently billed Medicaid for Assertive Community Treatment team services for 103 patients that it either failed to provide or document, federal law enforcement officials announced last week.

As part of the settlement, the organization admitted to billing for and receiving full monthly Medicaid payments for patients enrolled in its Far Rockaway ACT team program even though it was entitled only to partial payment based on the number of documented contacts with patients.

Assertive Community Treatment teams are community programs that serve individuals with severe mental illness who need a continuous high level of services.

Odds and Ends

NOW WE KNOW — A Texas hospital is experimenting with hologram doctors.

TODAY’S TIP — Test your fitness with these three exercises.

STUDY THIS — Older adults diagnosed with anxiety may be more likely to develop Parkinson’s disease, according to new research out of the U.K.

What We're Reading

An Alzheimer’s researcher at the City College of New York was charged with fraud. (The New York Times)

GOP leaders call for probes into alleged Affordable Care Act fraud. (The Washington Post)

Vape makers see U.S. Supreme Court ruling as a weapon in fighting the FDA. (STAT)

Around POLITICO

CMS aims to shield docs from billions in suspect spending, Robert King reports.

Via Lauren Gardner and David Lim: Chevron's demise could stall FDA rulemaking, former officials say.

MISSED A ROUNDUP? Get caught up on the New York Health Care Newsletter.

 

Follow us on Twitter

Maya Kaufman @mayakauf

 

Follow us

Follow us on Facebook Follow us on Twitter Follow us on Instagram Listen on Apple Podcast
 

To change your alert settings, please log in at https://login.politico.com/?redirect=https%3A%2F%2Fwww.politico.com/settings

This email was sent to salenamartine360.news1@blogger.com by: POLITICO, LLC 1000 Wilson Blvd. Arlington, VA, 22209, USA

Unsubscribe | Privacy Policy | Terms of Service

Post a Comment

Previous Post Next Post